153 results on '"Hajialilo, Mehrzad"'
Search Results
2. Serum salusin-β levels in patients with systemic lupus erythematosus
3. Prevalence and predictors of long-term remission in rheumatoid arthritis in real-world practice: a longitudinal study
4. The effect of osteoporotic and non-osteoporotic individuals’ T cell-derived exosomes on osteoblast cells’ bone remodeling related genes expression and alkaline phosphatase activity
5. Adalimumab‐induced leukocytoclastic vasculitis in a patient with ankylosing spondylitis: A case report.
6. Can treating rheumatoid arthritis with disease-modifying anti-rheumatic drugs at the window of opportunity with tight control strategy lead to long-term remission and medications free remission in real-world clinical practice? A cohort study
7. Factors associated with COVID-19 and its outcome in patients with rheumatoid arthritis
8. Efficacy of tight control strategy in the treatment of adult-onset Still disease
9. Nanocurcumin supplementation ameliorates Behcet’s disease by modulating regulatory T cells: A randomized, double‐blind, placebo‐controlled trial
10. Is Palindromic Rheumatism a Pre-rheumatoid Arthritis Condition? Low Incidence of Rheumatoid Arthritis in Palindromic Rheumatism Patients Treated with Tight Control Strategy
11. Cigarette smoking and risk of adult‐onset Still disease: a propensity score matching analysis.
12. Inflammatory myopathy in the proximal lower limb: Rare presentation of lymphoma
13. Endothelin-1, α-Klotho, 25(OH) Vit D levels and severity of disease in scleroderma patients
14. Survivin; a novel therapeutic target that correlates with survival of autoreactive T lymphocytes obtained from patients with ankylosing spondylitis
15. A double-blind randomized comparative study of triamcinolone hexacetonide and dexamethasone intra-articular injection for the treatment of knee joint arthritis in rheumatoid arthritis
16. Long-term efficacy and safety of interferon α-2a therapy in severe refractory ophthalmic Behcet’s disease
17. Clinical course, chest computed tomography severity score and outcome of coronavirus disease 2019 (COVID-19) in patients with rheumatic diseases
18. Additional file 2 of The effect of osteoporotic and non-osteoporotic individuals’ T cell-derived exosomes on osteoblast cells’ bone remodeling related genes expression and alkaline phosphatase activity
19. Additional file 3 of The effect of osteoporotic and non-osteoporotic individuals’ T cell-derived exosomes on osteoblast cells’ bone remodeling related genes expression and alkaline phosphatase activity
20. Long-term outcome and predictors of remission in Behçet’s disease in daily practice
21. Effects of melatonin supplementation on serum oxidative stress markers and disease activity in systemic lupus erythematosus patients: A randomised, double‐blind, placebo‐controlled trial
22. TNF-α gene polymorphisms in Iranian Azeri Turkish patients with Behcet’s Disease
23. Association between serum levels of survivin and systemic lupus erythematosus
24. Prevalence of COVID-19 in patients with rheumatoid arthritis (RA) already treated with hydroxychloroquine (HCQ) compared with HCQ-naive patients with RA: a multicentre cross-sectional study
25. Long‐term remission in patients with systemic lupus erythematosus
26. Clinical characteristics and long-term outcome of Takayasu arteritis in Iran: a multicentre study
27. Association between serum Toll-like receptor 4 and 8-hydroxy-2′-deoxyguanosine levels with disease activity in rheumatoid arthritis patients
28. Clinical Usefulness of Hematologic Indices as Predictive Parameters for Systemic Lupus Erythematosus
29. Effect of low-dose aspirin on platelet aggregation inhibition in patients with rheumatoid arthritis
30. Long-term outcome and predictors of remission in Behc¸et's disease in daily practice.
31. The effects of nanocurcumin on Treg cell responses and treatment of ankylosing spondylitis patients: A randomized, double‐blind, placebo‐controlled clinical trial
32. Nanocurcumin: A novel strategy in treating ankylosing spondylitis by modulating Th17 cells frequency and function
33. Clinical characteristics and long-term outcome of Takayasu arteritis in Iran: a multicentre study.
34. The effects of nanocurcumin on Treg cell responses and treatment of ankylosing spondylitis patients: A randomized, double‐blind, placebo‐controlled clinical trial.
35. Association of systemic lupus erythematosus activity with serum levelsof sTWEAK and CD160: A cross-sectional study
36. Long‐term follow‐up of 76 Iranian patients with idiopathic inflammatory myopathies
37. Comparison of International Study Group Criteria and International Criteria for Behcet's Disease in the Azeri population of Iran
38. Low dose cyclosporine A in the treatment of resistant proliferative lupus nephritis
39. Osteoprotegerin (OPG) levels, total soluble receptor activator of nuclear factor-Kappa B ligand (total sRANKL) , and RANKL/OPG ratio in patients with rheumatoid arteritis
40. Efficacy of Nigella sativa seeds oil in patients with Behcet's disease: a double-blind randomized controlled trial.
41. Risk Factors of Rheumatoid Arthritis Development Among Females in North-West of Iran: A Case-Control Study
42. Efficacy and Safety of Mycophenolate Mofetil Versus Intravenous Pulse Cyclophosphamide as Induction Therapy in Proliferative Lupus Nephritis.
43. Low dose cyclosporine A in the treatment of resistant proliferative lupus nephritis.
44. Effects of Vitamin K on Matrix Metalloproteinase-3 and Rheumatoid Factor in Women with Rheumatoid Arthritis: A Randomized, Double-Blind, Placebo-Controlled Trial
45. Nasal carriage rate of Staphylococcus aureus among patients with systemic lupus erythematosus and its correlation with disease relapse
46. Osteoprotegerin (OPG) and Matrix Gla protein (MGP) in rheumatoid arthritis patients: Relation to disease activity
47. Ankylosing Spondylitis in Iran; Late diagnosis and Its Causes
48. Prevalence of COVID-19 in patients with rheumatoid arthritis (RA) already treated with hydroxychloroquine (HCQ) compared with HCQ-naive patients with RA: a multicentre cross-sectional study.
49. Effects of Vitamin K on Matrix Metalloproteinase-3 and Rheumatoid Factor in Women with Rheumatoid Arthritis: A Randomized, Double-Blind, Placebo-Controlled Trial.
50. Fish oil supplementation decreases serum soluble receptor activator of nuclear factor-kappa B ligand/osteoprotegerin ratio in female patients with rheumatoid arthritis
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.